This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Pohang University of Science and Technology Foundation, Ulsan National Institute of Science and Technology. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Do Hui Kim: Innovator in Kidney Organoid Technology
Introduction
Do Hui Kim is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of regenerative medicine, particularly in the development of kidney organoids. His innovative work has the potential to advance research in kidney diseases and organ transplantation.
Latest Patents
Do Hui Kim holds a patent for "Kidney organoids and method for producing the same." This patent discloses a method for producing kidney organoids that includes several key steps. The process involves differentiating stem cells into metanephric mesenchyme cells, forming metanephric mesenchyme cell aggregates through culturing, and finally differentiating these aggregates into kidney organoids. This groundbreaking method represents a significant advancement in the field.
Career Highlights
Throughout his career, Do Hui Kim has worked with notable institutions such as the Postech Research and Business Development Foundation and the Ulsan National Institute of Science and Technology (UNIST). His work in these organizations has allowed him to collaborate with leading researchers and contribute to important scientific advancements.
Collaborations
Do Hui Kim has collaborated with esteemed colleagues, including Dong Sung Kim and Tae Eun Park. These partnerships have fostered a collaborative environment that enhances research and innovation in kidney organoid technology.
Conclusion
Do Hui Kim's contributions to the field of kidney organoids exemplify the impact of innovative research on medical science. His patent and collaborative efforts position him as a key figure in advancing regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile